Answers are grounded in this paper and cite their sources.
The optimization of immunosuppressive therapies resulted in the establishment of organ transplantation as long‐term therapy of many end‐stage diseases. However, late graft dysfunction and loss, in particular, are still major problems. Furthermore, with an increasing demand for transplantation, suboptimal grafts are increasingly used for transplantation. In those grafts alloantigen‐independent events that cannot be inhibited by established immunosuppressive therapies may be particularly detrimental.
No takes yet. Share an insight, caveat, or question.
Buelow et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: